Deutsch English Français

Contact

EP3597216

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3597216

EP3597216 - HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOF [Right-click to bookmark this link]
Status	The patent has been granted Status updated on 22.07.2022 Database last updated on 30.07.2024
Former	Grant of patent is intended Status updated on 18.04.2022
Former	Examination is in progress Status updated on 01.10.2021
Former	Request for examination was made Status updated on 24.07.2020
Former	The application has been published Status updated on 20.12.2019
Most recent event Tooltip	19.01.2024	Change - opposition data/opponents data or that of the opponents representative	published on 21.02.2024 [2024/08]
Applicant(s)	For all designated states E. R. Squibb & Sons, L.L.C. Route 206 and Province Line Road Princeton, NJ 08540 / US
	[2022/34]
Former [2020/04]	For all designated states E. R. Squibb & Sons, L.L.C. Route 206 and Province Line Road Princeton, NJ 08540 / US
Inventor(s)	01 / THUDIUM, Kent B. 700 Bay Road Redwood City, CA 94063 / US
	02 / KORMAN, Alan J. 700 Bay Road Redwood City, CA 94063 / US
	03 / LEBLANC, Heidi 700 Bay Road Redwood City, CA 94063 / US
	04 / YAMANAKA, Mark 2953 Amoroso Court Pleasanton, CA 94566 / US
	05 / SELBY, Mark 700 Bay Road Redwood City, CA 94063 / US
	06 / ZENS, Kyra, D. 1409A South Claremont Street San Mateo, CA 94402 / US
	[2020/15]
Former [2020/04]	01 / THUDIUM, Kent B. 700 Bay Road Redwood City, CA 94063 / US
	02 / KORMAN, Alan J. 700 Bay Road Redwood City, CA 94063 / US
	03 / LEBLANC, Heidi 700 Bay Road Redwood City, CA 94063 / US
	04 / YAMANAKA, Mark 2953 Amoroso Court Pleasanton, CA 94566 / US
	05 / SELBY, Mark 700 Bay Road Redwood City, CA 94063 / US
	06 / ZENS, Kyra, D. 521 Cottonwood Drive Milpitas, CA 95035 / US
Representative(s)	Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB
	[2022/34]
Former [2020/04]	Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE
Application number, filing date	19186310.9	11.08.2009
	[2020/04]
Priority number, date	US20080188548P	11.08.2008 Original published format: US 188548 P
	[2020/04]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3597216
	Date:	22.01.2020
	Language:	EN
	[2020/04]
	Type:	B1 Patent specification
	No.:	EP3597216
	Date:	24.08.2022
	Language:	EN
	[2022/34]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	03.01.2020
Classification	IPC:	A61P43/00, A61P31/12, A61P31/18, A61P35/00, A61P35/02, C07K16/28, A61K39/00	[2022/19]
	CPC:	C07K16/2803 (EP,CN,IL,KR,US); A61P31/12 (EP,IL); A61P31/18 (EP,IL); A61P35/00 (EP,IL,KR); A61P35/02 (EP,IL); A61P37/00 (EP,IL); (+) A61P37/04 (EP,IL); A61P43/00 (EP,IL); C07K16/2827 (EP,IL,US); A61K2039/505 (EP,IL,KR,US); A61K2039/507 (EP,IL,US); C07K2317/21 (EP,IL,KR,US); C07K2317/33 (KR); C07K2317/34 (EP,IL,US); C07K2317/73 (EP,IL,KR,US); C07K2317/76 (EP,IL,KR,US); C07K2317/92 (EP,CN,IL,KR,US) (-)
	Former IPC [2020/04]	A61K39/00, C07K17/00, A61K39/395, A61K51/10, C07K16/28
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2020/35]
Former [2020/04]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Title	German:	HUMANE ANTIKÖRPER MIT BINDUNG DES LYMPHOZYTENAKTIVIERUNGSGENS 3 (LAG-3) UND VERWENDUNGEN DAVON	[2020/04]
	English:	HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOF	[2020/04]
	French:	ANTICORPS HUMAINS QUI SE LIENT À L'ACTIVATION DES LYMPHOCYTES GÈNE-3 (LAG-3) ET LEURS UTILISATIONS	[2020/04]
Examination procedure	22.07.2020	Amendment by applicant (claims and/or description)
	22.07.2020	Examination requested [2020/35]
	22.07.2020	Date on which the examining division has become responsible
	04.10.2021	Despatch of a communication from the examining division (Time limit: M02)
	07.10.2021	Reply to a communication from the examining division
	19.04.2022	Communication of intention to grant the patent
	14.07.2022	Fee for grant paid
	14.07.2022	Fee for publishing/printing paid
	14.07.2022	Receipt of the translation of the claim(s)
Parent application(s) Tooltip	EP09807162.4 / EP2320940
	EP15156647.8 / EP2905030
Divisional application(s)	EP22185991.1 / EP4147714
Opposition(s)	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Abitz & Partner Postfach 86 01 09 81628 München / DE
		02 19.05.2023 22.05.2023 ADMISSIBLE Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Lederer PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE
		03 23.05.2023 24.05.2023 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		04 24.05.2023 25.05.2023 ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE
		05 24.05.2023 26.05.2023 ADMISSIBLE Appleyard Lees IP LLP 15 Clare Road HX1 2HY West Yorkshire, Halifax / GB Opponent's representative Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB
		[2024/08]
	Former [2024/04]
	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Abitz & Partner Arabellastraße 17 81925 München / DE
		02 19.05.2023 22.05.2023 ADMISSIBLE Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE
		03 23.05.2023 24.05.2023 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		04 24.05.2023 25.05.2023 ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE
		05 24.05.2023 26.05.2023 ADMISSIBLE Appleyard Lees IP LLP 15 Clare Road HX1 2HY West Yorkshire, Halifax / GB Opponent's representative Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB
	Former [2024/03]
	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Abitz & Partner Arabellastraße 17 81925 München / DE
		02 19.05.2023 22.05.2023 ADMISSIBLE Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE
		03 23.05.2023 24.05.2023 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		04 24.05.2023 25.05.2023 ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE
		05 24.05.2023 26.05.2023 ADMISSIBLE Appleyard Lees IP LLP 15 Clare Road HX1 2HY West Yorkshire, Halifax / GB Opponent's representative Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB
	Former [2023/48]
	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Abitz & Partner Arabellastraße 17 81925 München / DE
		02 19.05.2023 22.05.2023 ADMISSIBLE Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Ladendorf, Oliver Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE
		03 23.05.2023 24.05.2023 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		04 24.05.2023 25.05.2023 ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE
		05 24.05.2023 26.05.2023 ADMISSIBLE Appleyard Lees IP LLP 15 Clare Road HX1 2HY West Yorkshire, Halifax / GB Opponent's representative Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB
	Former [2023/27]
	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Heinemann, Monica Abitz & Partner Patentanwälte mbB Arabellastraße 17 81925 München / DE
		02 19.05.2023 22.05.2023 ADMISSIBLE Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Ladendorf, Oliver Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE
		03 23.05.2023 24.05.2023 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		04 24.05.2023 25.05.2023 ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE
		05 24.05.2023 26.05.2023 ADMISSIBLE Appleyard Lees IP LLP 15 Clare Road HX1 2HY West Yorkshire, Halifax / GB Opponent's representative Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB
	Former [2023/26]
	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Heinemann, Monica Abitz & Partner Patentanwälte mbB Arabellastraße 17 81925 München / DE
		02 19.05.2023 22.05.2023 ADMISSIBLE Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE Opponent's representative Ladendorf, Oliver Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE
		03 23.05.2023 24.05.2023 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		04 24.05.2023 25.05.2023 ADMISSIBLE Strawman Limited Orchard Lea Horns Lane Combe, Witney Oxfordshire OX29 8NH / GB Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE
		05 24.05.2023 Appleyard Lees IP LLP 15 Clare Road HX1 2HY West Yorkshire, Halifax / GB Opponent's representative Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB
	Former [2023/23]
	Opponent(s)	01 27.04.2023 28.04.2023 ADMISSIBLE Merck Sharp & Dohme LLC P.O. Box 2000 126 East Lincoln Ave Rahway, NJ 07065 / US Opponent's representative Heinemann, Monica Abitz & Partner Patentanwälte mbB Arabellastraße 17 81925 München / DE
	06.06.2023	Invitation to proprietor to file observations on the notice of opposition
	15.12.2023	Reply of patent proprietor to notice(s) of opposition
Fees paid	Renewal fee
	15.07.2019	Renewal fee patent year 03
	15.07.2019	Renewal fee patent year 04
	15.07.2019	Renewal fee patent year 05
	15.07.2019	Renewal fee patent year 06
	15.07.2019	Renewal fee patent year 07
	15.07.2019	Renewal fee patent year 08
	15.07.2019	Renewal fee patent year 09
	15.07.2019	Renewal fee patent year 10
	15.07.2019	Renewal fee patent year 11
	13.08.2020	Renewal fee patent year 12
	13.08.2021	Renewal fee patent year 13
	15.07.2022	Renewal fee patent year 14
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO9110682 (INST NAT SANTE RECH MED [FR], et al);
		[Y]WO9530750 (ROUSSY INST GUSTAVE [FR], et al);
		[Y]WO9703695 (APPLIED RESEARCH SYSTEMS [AN], et al);
		[Y]US6197524 (ROMAGNANI SERGIO [IT]);
	by applicant	US153043
		US4399216
		US4439196
		US4447233
		US4447224
		US4475196
		US4486194
		US4487603
		US4522811
		EP0154316
		US4596556
		US4634665
		WO8704462
		US4790824
		WO8901036
		US4816567
		EP0338841
		US4941880
		EP0401384
		US5064413
		WO9203918
		US5179017
		WO9312227
		US5223409
		US5225539
		US5312335
		WO9425585
		US5374548
		WO9429351
		US5383851
		US5399163
		US5399331
		US5403484
		US5416016
		US5427908
		US5476996
		US5530101
		US5545806
		US5545807
		US5569825
		US5571698
		US5580717
		US5585089
		WO9713852
		US5624821
		US5625126
		US5633425
		US5648260
		US5661016
		US5677425
		US5693762
		US5698767
		US5714350
		US5760185
		US5762905
		WO9824884
		US5770429
		US5789650
		US5811097
		US5814318
		WO9842752
		US5833943
		US5837243
		US5869046
	US5874299
	US5877397
	US5885793
	US5922845
	US5939598
	WO9945962
	US5969108
	WO9954342
	US6075181
	WO0037504
	US6090382
	WO0042072
	US6114598
	US6121022
	US6150584
	US6156313
	US6162963
	US6165745
	US6172197
	US6180370
	WO0109187
	US6194551
	WO0114424
	US6207156
	US6277375
	EP1176195
	US6350861
	WO0243478
	WO02092780
	WO02092812
	WO02096910
	US2002199213
	US6521404
	US6544731
	US6555313
	WO03035835
	US6582915
	US6593081
	WO03074679
	US2004110704
	US6794132
	US6818216
	US6827925
	US6914128
	US2005153394
	US6951646
	US2006004081
	US6989452
	US2006024317
	US7087600
	WO2006089231
	US7129261
	US2006247295
	WO2006121168
	WO2007005874
	WO2007038658
	WO2007051081
	WO2007059404
	WO2008083312
	WO2008103693
	WO2009045957
	WO2009054863
	WO2009073533
	WO2009073546
	Opposition	US2006240024
		WO2007005874
		WO2006121168
		WO2010019570
		WO9530750
		EP0758383
		WO2017037203
		EP2905030
		EP3597216

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p